tradingkey.logo
tradingkey.logo
Pesquisar

Transmedics Group Inc

TMDX
Adicionar à lista de desejos
63.200USD
+1.160+1.87%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
2.18BValor de mercado
12.52P/L TTM

Mais detalhes de Transmedics Group Inc Empresa

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Informações de Transmedics Group Inc

Código da empresaTMDX
Nome da EmpresaTransmedics Group Inc
Data de listagemMay 02, 2019
CEOHassanein (Waleed H)
Número de funcionários728
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 02
Endereço200 Minuteman Road
CidadeANDOVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01810
Telefone19785520900
Sitehttps://www.transmedics.com/
Código da empresaTMDX
Data de listagemMay 02, 2019
CEOHassanein (Waleed H)

Executivos da empresa Transmedics Group Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
185.21K
+4.32%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.18K
+0.41%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
--
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
--
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
3.00K
+88.95%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
2.87K
-41.63%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
185.21K
+4.32%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.18K
+0.41%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
--
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
OCS Liver net revenue
460.53M
76.58%
OCS Heart net revenue
126.01M
20.95%
OCS Lung net revenue
14.86M
2.47%
Por RegiãoUSD
Nome
Receita
Proporção
United States
584.70M
97.22%
All other countries
16.70M
2.78%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
OCS Liver net revenue
460.53M
76.58%
OCS Heart net revenue
126.01M
20.95%
OCS Lung net revenue
14.86M
2.47%

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.92%
Fidelity Management & Research Company LLC
12.93%
Vanguard Portfolio Management, LLC
5.55%
Vanguard Capital Management, LLC
4.28%
State Street Investment Management (US)
3.69%
Outro
59.63%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.92%
Fidelity Management & Research Company LLC
12.93%
Vanguard Portfolio Management, LLC
5.55%
Vanguard Capital Management, LLC
4.28%
State Street Investment Management (US)
3.69%
Outro
59.63%
Tipos de investidores
Investidores
Proporção
Investment Advisor
73.74%
Investment Advisor/Hedge Fund
24.06%
Hedge Fund
5.98%
Research Firm
4.71%
Individual Investor
3.29%
Bank and Trust
2.16%
Pension Fund
1.28%
Family Office
0.17%
Sovereign Wealth Fund
0.09%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
865
42.29M
122.36%
-1.74M
2025Q4
802
38.01M
111.22%
-5.64M
2025Q3
762
37.62M
110.09%
-8.17M
2025Q2
746
42.27M
124.01%
-2.30M
2025Q1
751
42.32M
125.08%
-2.32M
2024Q4
728
40.09M
119.11%
-642.74K
2024Q3
673
39.30M
117.10%
+1.37M
2024Q2
615
36.53M
110.85%
-3.27M
2024Q1
544
37.44M
113.97%
-4.28M
2023Q4
512
38.18M
116.94%
-3.46M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
4.81M
14.02%
+72.53K
+1.53%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.47M
13.03%
-128.10K
-2.79%
Dec 31, 2025
State Street Investment Management (US)
1.28M
3.72%
-4.41K
-0.34%
Dec 31, 2025
Nomura Investment Management Business Trust
832.24K
2.43%
-74.03K
-8.17%
Dec 31, 2025
Geode Capital Management, L.L.C.
816.47K
2.38%
+2.90K
+0.36%
Dec 31, 2025
Two Sigma Investments, LP
800.39K
2.33%
-258.30K
-24.40%
Dec 31, 2025
Driehaus Capital Management, LLC
712.04K
2.08%
-26.12K
-3.54%
Dec 31, 2025
Hood River Capital Management LLC
690.36K
2.01%
+11.92K
+1.76%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Global X HealthTech ETF
4.75%
Clough Select Equity ETF
2.87%
Invesco S&P SmallCap Health Care ETF
2.75%
State Street SPDR S&P Health Care Equipment ETF
2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.47%
iShares S&P Small-Cap 600 Growth ETF
0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.58%
Ver Mais
Global X HealthTech ETF
Proporção4.75%
Clough Select Equity ETF
Proporção2.87%
Invesco S&P SmallCap Health Care ETF
Proporção2.75%
State Street SPDR S&P Health Care Equipment ETF
Proporção2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporção1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção1.47%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporção0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporção0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporção0.58%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI